title: [Proteinuria after infusion of gelatin. Comparison of Plasmion and Haemaccel].
abstract: Modified gelatin are said without deleterious effect on kidney, an important proteinuria as been seen however in surgical patients after gelatin perfusion. A study in 15 patients scheduled for abdominal surgery compared the renal effects of two modified gelatin: Plasmion (gr P) and Haemaccel (gr H) administered in a similar manner. In the two groups proteinuria appears as soon as perfusion begins with at the third hour a peak which may be as high as 6 g/l. In the same time low molecular weight proteinuria (less than 30 kdalton) appears. The beta 2 microglobulinuria (beta 2m) is significatively enhanced (p less than 0,001). Albuminuria is also enhanced but without statistic signification. Comparison between the two groups reveals that in gr P proteinuria is of the same importance, but delayed, with a significatively smaller elimination of beta 2m (1,8 mg/mmol creatininuria versus 8,6,p less than 0,001). Enzymuria increases in a variable fashion. Proteinuria is probably due to tubular reabsorption inhibition of filtered protein induced by gelatin, particularly by amino acids arginine and lysin which become free after gelatin hydrolysis. If this phenomenon is pathologic or not is unclear and gelatin cannot be said absolutely innocuous. However this phenomenon must be known when proteinuria specially beta 2m is to be interpreted.
authors.forename: T
authors.initials: T
authors.lastname: Lazard
authors.forename: I
authors.initials: I
authors.lastname: Deswartes-Pipien
authors.forename: D
authors.initials: D
authors.lastname: Tenenhaus
authors.forename: H
authors.initials: H
authors.lastname: Voitot
authors.forename: F
authors.initials: F
authors.lastname: Drupt
authors.forename: N
authors.initials: N
authors.lastname: Desveaux
authors.forename: M T
authors.initials: MT
authors.lastname: Cousin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D004341:Drug Evaluation; D005260:Female; D005780:Gelatin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010477:Perfusion; D011097:Polygeline / Q000008:administration & dosage / Q000009:adverse effects*; D011108:Polymers / Q000009:adverse effects*; D011507:Proteinuria / Q000139:chemically induced*; D011897:Random Allocation
chemical_list: D011108:Polymers; C013648:plasmion; D005780:Gelatin; D011097:Polygeline
vernacular_title: Protéinurie après perfusion de gélatine. Comparaison entre Plasmion et Haemaccel.